Unicycive Therapeutics, Inc.
USD4.69
-3.01 (-39.09%)
CEO
Shalabh K. Gupta
IPO Date
2021-07-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.00
Prev. Close
$7.70
Day Low
$3.99
Day High
$4.92
52W Low
$3.71
52W High
$8.74
Market Cap
$0.10B
Volume
19.69M
| -1.4 |
| 31 Dec 2023 | FY | 100.0% | -4525.0% | 801.9% | -215.2% | -0.21 | 0.76 | -0.7 |
| 31 Dec 2022 | FY | 100.0% | -1898.8% | 3875.1% | -640.8% | -0.43 | 0.81 | -0.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -60.8% | -53.4% | 0.02 | 8.75 | -2.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 93.9% | -1229.4% | -0.94 | 0.07 | -30.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 260.6% | -12126.3% | -0.52 | 0.02 | -18.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 92.9% | -3862.1% | -0.87 | 0.02 | -35.5 |
| -15.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -16.0% | -11.9% | 0.01 | 3.83 | -3.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -39.2% | -21.5% | 0.03 | 2.18 | -2.3 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 5.1% | 2.0% | 0.06 | 1.64 | 29.5 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -289.7% | -68.0% | 0.10 | 1.28 | -0.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -14.7% | -10.6% | 0.03 | 3.61 | -2.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 31.4% | 22.0% | 0.02 | 3.37 | 0.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -96.5% | -40.0% | 0.03 | 1.71 | -0.6 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 204.7% | -55.0% | -0.21 | 0.76 | -1.0 |